Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ferric Hydroxide-polymaltose
2. Ferric Polymaltose
3. Ferripolyisomaltose
4. Ferrum Hausmann
5. Intrafer
6. Iron Hydroxide Polymaltose
7. Iron(iii)-hydroxide-dextrin
8. Iron-polymaltose Complex
9. Noripurum
10. Teferrol
1. Ferrummate
2. Amylofer
3. Maltofer
4. Ferripel 3
5. 53858-86-9
6. Um5219h89v
7. Teferrol
8. Ferrum Hausmann
9. Iron(3+);(2r,3s,4r,5r)-2,3,4,5-tetrahydroxy-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanal;trihydroxide
10. Injectafer
11. Ferinject
12. Ferripel-3
13. Ferromaltose
14. Unii-um5219h89v
15. Ferric Hydroxide Polymaltose Complex
16. Iron(iii)-hydroxide Polymaltose Complex
17. Ferric Hydroxide Polymaltose Complex [who-dd]
18. Q27291136
Molecular Weight | 449.16 g/mol |
---|---|
Molecular Formula | C12H25FeO14 |
Hydrogen Bond Donor Count | 11 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 8 |
Exact Mass | 449.059366 g/mol |
Monoisotopic Mass | 449.059366 g/mol |
Topological Polar Surface Area | 200 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 367 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 5 |
Hematinics
Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. (See all compounds classified as Hematinics.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33717
Submission : 2019-05-07
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33716
Submission : 2019-04-10
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32220
Submission : 2017-10-31
Status : Active
Type : II
Date of Issue : 2022-04-05
Valid Till : 2025-07-28
Written Confirmation Number : WC-0449A1
Address of the Firm : 75/2 National Highway No 6 Malkapur
iron hydroxide polymaltose/ Iron protein succinylate
Date of Issue : 2019-07-29
Valid Till : 2022-07-28
Written Confirmation Number : WC-0449
Address of the Firm : 75/2 National Highway No 6 Malkapur
Date of Issue : 2021-01-08
Valid Till : 2025-01-08
Written Confirmation Number : WC-0490A2
Address of the Firm : Block No 63, Bileshwarpura, P.O Chhatral,\r\nKalol-Mehsana Highway, Gandhinagar-...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Brand Name : AFFINISOL HPMC HME
Application : Solubilizers
Excipient Details : Solubility enhancement, Spray-Dried Dispersion (SDD), Hot Melt Extrusion (HME)
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet
Grade : Oral
Category : Solubilizers
Application : Solubilizers
Excipient Details : A & C's Maltodextrin is an excipient which meets the NF monograph.
Dosage Form : Capsule, Softgel Capsule, Softgels, Tablet
Grade : Not Available
Category : Solubilizers, Taste Masking, Thickeners and Stabilizers
Brand Name : Hydroxypropyl Methyl Cellulose
Application : Coating Systems & Additives
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Emulsion, Tablet
Grade : Oral, Ophthalmic
Category : Disintegrants & Superdisintegrants, Emulsifying Agents, Film Formers & Plasticizers, Thickeners and Stabilizers
Brand Name : Hydroxypropyl Methyl Cellulose
Application : Disintegrants & Superdisintegrants, Emulsifying Agents, Film Formers & Plasticizers, Thickeners and Stabilizers
Excipient Details : Hydroxypropyl Methyl Cellulose is used as a film-former, disintegrant, thickener, and emulsifier in tablets, emulsions, and ophthalmic formulations.
Dosage Form : Cream / Lotion / Ointment, Tablet
Grade : Oral
Category : Emulsifying Agents, Lubricants & Glidants, Thickeners and Stabilizers
Application : Emulsifying Agents, Lubricants & Glidants, Thickeners and Stabilizers
Global Sales Information
PHARMADAY Srl
Iron III Hydroxide Polymaltose Complex
Dosage Form : Iron Polimaltosato 50Mg/Ml 30Ml ...
Dosage Strength : os gtt 30 ml 50 mg/ml
Price Per Pack (Euro) : 5.21
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Market Place
Reply
13 Nov 2017
ABOUT THIS PAGE
A Iron III Hydroxide Polymaltose Complex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Iron III Hydroxide Polymaltose Complex, including repackagers and relabelers. The FDA regulates Iron III Hydroxide Polymaltose Complex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Iron III Hydroxide Polymaltose Complex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Iron III Hydroxide Polymaltose Complex manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Iron III Hydroxide Polymaltose Complex supplier is an individual or a company that provides Iron III Hydroxide Polymaltose Complex active pharmaceutical ingredient (API) or Iron III Hydroxide Polymaltose Complex finished formulations upon request. The Iron III Hydroxide Polymaltose Complex suppliers may include Iron III Hydroxide Polymaltose Complex API manufacturers, exporters, distributors and traders.
click here to find a list of Iron III Hydroxide Polymaltose Complex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Iron III Hydroxide Polymaltose Complex DMF (Drug Master File) is a document detailing the whole manufacturing process of Iron III Hydroxide Polymaltose Complex active pharmaceutical ingredient (API) in detail. Different forms of Iron III Hydroxide Polymaltose Complex DMFs exist exist since differing nations have different regulations, such as Iron III Hydroxide Polymaltose Complex USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Iron III Hydroxide Polymaltose Complex DMF submitted to regulatory agencies in the US is known as a USDMF. Iron III Hydroxide Polymaltose Complex USDMF includes data on Iron III Hydroxide Polymaltose Complex's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Iron III Hydroxide Polymaltose Complex USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Iron III Hydroxide Polymaltose Complex suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Iron III Hydroxide Polymaltose Complex Drug Master File in Korea (Iron III Hydroxide Polymaltose Complex KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Iron III Hydroxide Polymaltose Complex. The MFDS reviews the Iron III Hydroxide Polymaltose Complex KDMF as part of the drug registration process and uses the information provided in the Iron III Hydroxide Polymaltose Complex KDMF to evaluate the safety and efficacy of the drug.
After submitting a Iron III Hydroxide Polymaltose Complex KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Iron III Hydroxide Polymaltose Complex API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Iron III Hydroxide Polymaltose Complex suppliers with KDMF on PharmaCompass.
A Iron III Hydroxide Polymaltose Complex written confirmation (Iron III Hydroxide Polymaltose Complex WC) is an official document issued by a regulatory agency to a Iron III Hydroxide Polymaltose Complex manufacturer, verifying that the manufacturing facility of a Iron III Hydroxide Polymaltose Complex active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Iron III Hydroxide Polymaltose Complex APIs or Iron III Hydroxide Polymaltose Complex finished pharmaceutical products to another nation, regulatory agencies frequently require a Iron III Hydroxide Polymaltose Complex WC (written confirmation) as part of the regulatory process.
click here to find a list of Iron III Hydroxide Polymaltose Complex suppliers with Written Confirmation (WC) on PharmaCompass.
Iron III Hydroxide Polymaltose Complex Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Iron III Hydroxide Polymaltose Complex GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Iron III Hydroxide Polymaltose Complex GMP manufacturer or Iron III Hydroxide Polymaltose Complex GMP API supplier for your needs.
A Iron III Hydroxide Polymaltose Complex CoA (Certificate of Analysis) is a formal document that attests to Iron III Hydroxide Polymaltose Complex's compliance with Iron III Hydroxide Polymaltose Complex specifications and serves as a tool for batch-level quality control.
Iron III Hydroxide Polymaltose Complex CoA mostly includes findings from lab analyses of a specific batch. For each Iron III Hydroxide Polymaltose Complex CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Iron III Hydroxide Polymaltose Complex may be tested according to a variety of international standards, such as European Pharmacopoeia (Iron III Hydroxide Polymaltose Complex EP), Iron III Hydroxide Polymaltose Complex JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Iron III Hydroxide Polymaltose Complex USP).
LOOKING FOR A SUPPLIER?